A researcher has been working on a study about the potential positive effects of a cancer drug on Alzheimer's disease. Boris Decourt, who has spent over 15 years in the field, has been part of Alzheimer's research since 2009. He has been investigating the abnormal accumulation of proteins in the brain, including amyloid-beta plaques and tau tangles, which affect memory, thinking, and behavior.

Decourt's approach differs from traditional methods, which have focused on removing these proteins. Further details about the study and its findings are available from the source. Decourt's work is part of ongoing efforts by researchers worldwide to find a solution to Alzheimer's disease.